Your browser doesn't support javascript.
loading
Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial.
Pontes-García, A; Martínez-López, A; Rodríguez-Ortiz, L; Valenzuela-Molina, F; Rufián-Andújar, B; Sánchez-Hidalgo, J M; Casado-Adam, A; Gordon-Suarez, A; Rufián-Peña, S; Vázquez-Borrego, M C; Romero-Ruiz, A; Arjona-Sánchez, A.
Afiliação
  • Pontes-García A; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain.
  • Martínez-López A; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain; Unit of Pathology, Reina Sofia University H
  • Rodríguez-Ortiz L; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Valenzuela-Molina F; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Rufián-Andújar B; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Sánchez-Hidalgo JM; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Casado-Adam A; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Gordon-Suarez A; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Rufián-Peña S; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
  • Vázquez-Borrego MC; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain.
  • Romero-Ruiz A; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain.
  • Arjona-Sánchez A; Unit of Surgical Oncology, Reina Sofía University Hospital, Córdoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, Univer
Eur J Surg Oncol ; 49(9): 106978, 2023 09.
Article em En | MEDLINE | ID: mdl-37460370

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Gases em Plasma / Hipertermia Induzida Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Gases em Plasma / Hipertermia Induzida Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Eur J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha